Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

NCT02613026 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Pirarubicin
DRUG: Docetaxel
DRUG: Cyclophosphamide

Sponsor

307 Hospital of PLA